Elazer Edelman
Cardiovascular Disease · Boston, MANPI 1659369460
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 4 manufacturers reported payments, led by AbbVie at 59.9% of the total. Reporting peaked in 2020 at $6,040 and has fallen 89.9% since, to $610 in 2024.
Across 23 payments — averaging $721.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$10K
- Abiomed$7K
- Edwards Lifesciences$104
- Heartflow, Inc.$28
Across 14 payments — averaging $54,607 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Shockwave Medical, Inc$489K
- Edwards Lifesciences$275K
What the payments were for
- Consulting fees$9,93860%
- Travel & lodging$6,47039%
- Food & beverage$1811%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 2 | $9,938 |
| Abiomed | 19 | $6,520 |
| Edwards Lifesciences | 1 | $104 |
| Heartflow, Inc. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$6,319
How this compares
$16,589 in reported general payments places this provider in the 80th percentile of 750 cardiovascular disease providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Boston
- Marc SabatineBoston$3.9M
- Elizabeth NabelBoston$2.2M
- Kenneth RosenfieldBoston$1.4M
- James JanuzziBoston$1.1M
- Muthiah VaduganathanBoston$972K
- Joseph LoscalzoBoston$926K
- Sunil KapurBoston$823K
- Paul ZeiBoston$786K
- Paul RidkerBoston$572K
- Ignacio Inglessis-AzuajeBoston$545K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.